Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
(Q44656909)
scientific article published in August 1995
scientific article published in August 1995
Language:
Current Data About
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
other details
description | scientific article published in August 1995 |
External Links
(P356) |
10.1016/S0140-6736(95)92225-3
|
(P698) |
7623531
|